#######################
# Document Properties #
#######################
SET DOCUMENT Copyright   = "Copyright © 2018 Fraunhofer Institute SCAI, All rights reserved."
SET DOCUMENT Licenses    = "CC BY 4.0"
SET DOCUMENT ContactInfo = "charles.hoyt@scai.fraunhofer.de"

SET DOCUMENT Name        = "Tau Internalization is Regulated by 6-O Sulfation on Heparan Sulfate Proteoglycans (HSPGs)"
SET DOCUMENT Version     = "1.0.1"
SET DOCUMENT Authors     = "Sandra Spalek"
SET DOCUMENT Description = ""

##############
# Namespaces #
##############

# Namespaces hosted on https://github.com/pharmacome/terminology
# --------------------------------------------------------------
DEFINE NAMESPACE CHEBI          AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/chebi-names.belns"
DEFINE NAMESPACE DRUGBANK       AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/drugbank-names.belns"
DEFINE NAMESPACE ECCODE         AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/ec-code.belns"
# DEFINE NAMESPACE FB           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/80171ae62cf43aa1fc8a6c326b94537ab342458c/external/fb-names.belns"
DEFINE NAMESPACE HBP            AS URL "https://raw.githubusercontent.com/pharmacome/terminology/7e4be528f12abd28be768b62402fba6e083eaf9e/export/hbp-names.belns"
DEFINE NAMESPACE HGNC           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc-names.belns"
DEFINE NAMESPACE HGNCGENEFAMILY AS URL "https://raw.githubusercontent.com/pharmacome/terminology/3074b85b858455d8eeb76cfcdef685ced19bbe11/external/hgnc.genefamily-names.belns"
DEFINE NAMESPACE GO             AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/go-names.belns"
DEFINE NAMESPACE INTERPRO       AS URL "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/interpro-names.belns"
DEFINE NAMESPACE MESH           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/8ccfed235e418e4c8aa576f9a5ef0f838e794c7f/external/mesh-names.belns"
DEFINE NAMESPACE MGI            AS URL "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/mgi-names.belns"
DEFINE NAMESPACE MIRBASE        AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/mirbase-names.belns"
DEFINE NAMESPACE NCBIGENE       AS URL "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/entrez.belns"
DEFINE NAMESPACE PFAM           AS URL "https://raw.githubusercontent.com/pharmacome/terminology/8ccfed235e418e4c8aa576f9a5ef0f838e794c7f/external/pfam-names.belns"
DEFINE NAMESPACE RGD            AS URL "https://raw.githubusercontent.com/pharmacome/terminology/f2f993e599694ab5ce989cc39d789a499f75db99/external/rgd-names.belns"

# Namespaces hosted on https://github.com/sorgerlab/famplex
# ---------------------------------------------------------
DEFINE NAMESPACE FPLX           AS URL "https://raw.githubusercontent.com/sorgerlab/famplex/e8ae9926ff95266032cb74f77973c84939bffbeb/export/famplex.belns"

# Namespaces hosted on https://arty.scai.fraunhofer.de/artifactory/bel/namespace
# ------------------------------------------------------------------------------
DEFINE NAMESPACE CTO            AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/clinical-trial-ontology/clinical-trial-ontology-1.0.0.belns"
DEFINE NAMESPACE DO             AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/disease-ontology/disease-ontology-20170725.belns"
DEFINE NAMESPACE HP             AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20171108.belns"
DEFINE NAMESPACE SCOMP          AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-named-complexes/selventa-named-complexes-20170725.belns"
DEFINE NAMESPACE SFAM           AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/selventa-protein-families/selventa-protein-families-20170725.belns"

# Namespaces defined with regular expressions
# -------------------------------------------
DEFINE NAMESPACE DBSNP          AS PATTERN "rs[0-9]+"
DEFINE NAMESPACE TAXONOMY       AS PATTERN "^\d+$"
DEFINE NAMESPACE UNIPROT        AS PATTERN "^([A-N,R-Z][0-9]([A-Z][A-Z, 0-9][A-Z, 0-9][0-9]){1,2})|([O,P,Q][0-9][A-Z, 0-9][A-Z, 0-9][A-Z, 0-9][0-9])(\.\d+)?$"
DEFINE NAMESPACE PUBCHEM        AS PATTERN "^\d+$"

###############
# Annotations #
###############

# Annotations defined with regular expressions
# --------------------------------------------
DEFINE ANNOTATION Species       AS PATTERN "^\d+$"

# Annotations hosted on https://arty.scai.fraunhofer.de/artifactory/bel/annotation
# --------------------------------------------------------------------------------
DEFINE ANNOTATION Anatomy       AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno"
DEFINE ANNOTATION CellLine      AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno"
DEFINE ANNOTATION CellStructure AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno"
DEFINE ANNOTATION Cell          AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno"
DEFINE ANNOTATION Confidence    AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno"
DEFINE ANNOTATION Disease       AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno"
DEFINE ANNOTATION Gender        AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/gender/gender-1.0.0.belanno"
DEFINE ANNOTATION MeSHAnatomy   AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno"
DEFINE ANNOTATION MeSHDisease   AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno"
DEFINE ANNOTATION Subgraph      AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno"
DEFINE ANNOTATION TextLocation  AS URL "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"

##############
# Statements #
##############
SET Citation = {"PubMed", "29686391"}

SET Evidence = "Tau protein can form multiple quaternary structures in solution, and recent evidence suggests that small tau oligomeric species may
play a critical role in the spread of tau pathology and neurotoxicity"
a(HBP:"Tau oligomers") positiveCorrelation path(MESH:Tauopathies)
a(HBP:"Tau oligomers") positiveCorrelation bp(HBP:neurotoxicity)

SET Evidence = "Monomeric, oligomeric and sonicated fibrils were efficiently internalized, while fibril samples were not
(Fig. 1c and Supplementary Fig. 1d)"
a(HBP:"Tau isoform F (441 aa)") positiveCorrelation tloc(a(HBP:"Tau isoform F (441 aa)"),fromLoc(GO:"extracellular region"),toLoc(GO:intracellular))
a(HBP:"Tau oligomers") positiveCorrelation tloc(a(HBP:"Tau oligomers"),fromLoc(GO:"extracellular region"),toLoc(GO:intracellular))
a(HBP:"sonicated tau fibrils") positiveCorrelation tloc(a(HBP:"sonicated tau fibrils"),fromLoc(GO:"extracellular region"),toLoc(GO:intracellular))

SET Evidence = "Further, human iPS-derived neurons also showed a preference for smaller structures of
tau, with fibrillized tau showing nearly no uptake (Fig. 1d)"
SET MeSHAnatomy = "Neurons"
a(HBP:"Tau isoform F (441 aa)") -> tloc(a(HBP:"Tau isoform F (441 aa)"),fromLoc(GO:"extracellular region"),toLoc(GO:intracellular))
a(HBP:"Tau fibrils") cnc tloc(a(HBP:"Tau fibrils"),fromLoc(GO:"extracellular region"),toLoc(GO:intracellular))
UNSET MeSHAnatomy

SET Evidence = "The selective knockdown of genes such as TP53, led to a
decrease in G1 length and thus an overall increase in cell proliferation (Supplementary Fig. 2d)"
g(HGNC:TP53) -> bp(GO:"mitotic G1 phase")
g(HGNC:TP53) -| bp(GO:"cell proliferation")

# Tau refers to 2N4R tau

SET Evidence = "Endocytosis is known to increase during G1 phase25; therefore, it seemed logical that cell cycle regulators that can shorten the
G1 phase could reduce the amount of tau uptake and vice versa."
bp(GO:"mitotic G1 phase") positiveCorrelation bp(GO:endocytosis)
bp(GO:"mitotic G1 phase") reg tloc(a(HBP:"Tau isoform F (441 aa)"),fromLoc(GO:"extracellular region"),toLoc(GO:intracellular))

SET Evidence = "In line with these observations a small molecule
inhibitor of CDK4/6 that causes a stall in G1 phase (PD0332991) was sufficient to almost double the amount of
tau taken up in H4 cells (Supplementary Fig. 2e)"
p(HGNC:CDK4) -| tloc(a(HBP:"Tau isoform F (441 aa)"),fromLoc(GO:"extracellular region"),toLoc(GO:intracellular))
p(HGNC:CDK6) -| tloc(a(HBP:"Tau isoform F (441 aa)"),fromLoc(GO:"extracellular region"),toLoc(GO:intracellular))
a(CHEBI:palbociclib) -> tloc(a(HBP:"Tau isoform F (441 aa)"),fromLoc(GO:"extracellular region"),toLoc(GO:intracellular))
a(CHEBI:palbociclib) -| act(p(HGNC:CDK4))
a(CHEBI:palbociclib) -| act(p(HGNC:CDK6))

SET Evidence = "These single gene knockdowns repressed
uptake of tau monomer by over 50% (Fig. 2b) and also reduced the uptake of tau oligomers (Fig. 2c)"
# KO of EXT2, HS6ST1, DNM2
p(HGNC:EXT2) -- bp(GO:"heparan sulfate proteoglycan biosynthetic process")
p(HGNC:HS6ST1) -- bp(GO:"heparan sulfate proteoglycan biosynthetic process")
p(HGNC:EXT2) -> tloc(a(HBP:"Tau isoform F (441 aa)"),fromLoc(GO:"extracellular region"),toLoc(GO:intracellular))
p(HGNC:EXT2)  -> tloc(a(HBP:"Tau oligomers"),fromLoc(GO:"extracellular region"),toLoc(GO:intracellular))
p(HGNC:HS6ST1) -> tloc(a(HBP:"Tau isoform F (441 aa)"),fromLoc(GO:"extracellular region"),toLoc(GO:intracellular))
p(HGNC:HS6ST1) -> tloc(a(HBP:"Tau oligomers"),fromLoc(GO:"extracellular region"),toLoc(GO:intracellular))
p(HGNC:DNM2) -> tloc(a(HBP:"Tau isoform F (441 aa)"),fromLoc(GO:"extracellular region"),toLoc(GO:intracellular))
p(HGNC:DNM2) -> tloc(a(HBP:"Tau oligomers"),fromLoc(GO:"extracellular region"),toLoc(GO:intracellular))

SET Evidence = "Further, these
gene knockdowns were sufficient to reduce the uptake of tau in iPS-derived neurons (Fig. 2d)"
# KO of EXT2, HS6ST1, DNM2
SET MeSHAnatomy = "Neurons"
p(HGNC:EXT2) -> tloc(a(HBP:"Tau isoform F (441 aa)"),fromLoc(GO:"extracellular region"),toLoc(GO:intracellular))
p(HGNC:HS6ST1) -> tloc(a(HBP:"Tau isoform F (441 aa)"),fromLoc(GO:"extracellular region"),toLoc(GO:intracellular))
p(HGNC:DNM2) -> tloc(a(HBP:"Tau isoform F (441 aa)"),fromLoc(GO:"extracellular region"),toLoc(GO:intracellular))
UNSET MeSHAnatomy

SET Evidence = "Treatment of cells
with an inhibitor for DNM2, Dynasore, was also able to reduce uptake of tau (Supplementary Fig. 2 f)"
a(CHEBI:dynasore) -| tloc(a(HBP:"Tau isoform F (441 aa)"),fromLoc(GO:"extracellular region"),toLoc(GO:intracellular))

SET Evidence = "Previous
reports had indicated that internalization of tau could be regulated by HSPGs16, but our identification of HS6ST1,
an enzyme that is responsible for 6-O-sulfation of HSPGs, supports a hypothesis that specific motifs on HSPGs
might be important for tau uptake"
p(HGNC:HS6ST1) -> a(HBP:"6-O-sulfated heparin")

SET Evidence = "Tau bound heparin with an affinity of 4.6 ± 0.6 nM, consistent with previous
reports"
complex(a(HBP:"Tau isoform F (441 aa)"),a(CHEBI:heparin))

SET Evidence = "Over sulfated heparin (>3 sulfates per disaccharide) bound tau even tighter (2.2 ± 0.5 nM), while
fully-desulfated heparin showed a drastically reduced binding (>1 μM) (Fig. 3c)"
complex(a(MESH:"Heparitin Sulfate"),a(HBP:"Tau isoform F (441 aa)"))

SET Evidence = "Removal of N-sulfates or 2-O-sulfates
had little effect on tau binding (15.0 ± 5 nM and 7.4 ± 1.0 nM, respectively), while removal of all O-sulfates and, in particular
6-O-sulfates, led to a significant decrease in tau binding (>1 μM in each case; Fig. 3c,d)"
a(HBP:"6-O-sulfated heparin") positiveCorrelation complex(a(HBP:"6-O-sulfated heparin"),a(HBP:"Tau isoform F (441 aa)"))

SET Evidence = "We found that internalization of tau can be efficiently competed by
the presence of heparin or HS in the media (Fig. 4a)"
a(CHEBI:heparin) -- tloc(a(HBP:"Tau isoform F (441 aa)"),fromLoc(GO:"extracellular region"),toLoc(GO:intracellular))

SET Evidence = "Likewise, addition of 2-O-desulfated heparin was able to
reduce uptake, whereas 6-O-desulfated heparin or chondroitin sulfate (negative control) were significantly less
effective at reducing uptake (Fig. 4a)"
a(HBP:"6-O-sulfated heparin") -> tloc(a(HBP:"Tau isoform F (441 aa)"),fromLoc(GO:"extracellular region"),toLoc(GO:intracellular))
a(HBP:"2-O-sulfated heparin") -> tloc(a(HBP:"Tau isoform F (441 aa)"),fromLoc(GO:"extracellular region"),toLoc(GO:intracellular))
a(CHEBI:"chondroitin sulfate") -| tloc(a(HBP:"Tau isoform F (441 aa)"),fromLoc(GO:"extracellular region"),toLoc(GO:intracellular))

SET Evidence = "These results were consistent when tested in iPS-derived neurons (Fig. 4b),
demonstrating that the 6-O-sulfation motif is indeed a critical determinant for cellular tau entry"
SET MeSHAnatomy = "Neurons"
a(HBP:"6-O-sulfated heparin") -- tloc(a(HBP:"Tau isoform F (441 aa)"),fromLoc(GO:"extracellular region"),toLoc(GO:intracellular))
UNSET MeSHAnatomy

SET Evidence = "Consistent with our previous results, incubation with heparin, heparan sulfate, or 2-O-desulfated heparin
reduced uptake of tau as quantified by the median 488 fluorescence intensity (Fig. 4d)"
a(CHEBI:heparin) -| tloc(a(HBP:"Tau isoform F (441 aa)"),fromLoc(GO:"extracellular region"),toLoc(GO:intracellular))
a(MESH:"Heparitin Sulfate") -| tloc(a(HBP:"Tau isoform F (441 aa)"),fromLoc(GO:"extracellular region"),toLoc(GO:intracellular))
a(HBP:"2-O-sulfated heparin") -> tloc(a(HBP:"Tau isoform F (441 aa)"),fromLoc(GO:"extracellular region"),toLoc(GO:intracellular))

SET Evidence = "Chondroitin sulfate
and 6-O-desulfated heparin incubation did not reduce the median fluorescence, verifying that 6-O-sulfation
is also important for tau internalization ex vivo (Fig. 4d and Supplementary Fig. 3b)"
a(HBP:"6-O-sulfated heparin") -> tloc(a(HBP:"Tau isoform F (441 aa)"),fromLoc(GO:"extracellular region"),toLoc(GO:intracellular))
a(CHEBI:"chondroitin sulfate") cnc tloc(a(HBP:"Tau isoform F (441 aa)"),fromLoc(GO:"extracellular region"),toLoc(GO:intracellular))

SET Evidence = "Overexpression of these enzymes in H4 cells, showed a dramatic decrease in tau uptake
with Sulf1 reducing uptake to 17 ± 9%, and Sulf2 reducing uptake to 36 ± 15% (Fig. 4e)"
p(HGNC:SULF1) -| tloc(a(HBP:"Tau isoform F (441 aa)"),fromLoc(GO:"extracellular region"),toLoc(GO:intracellular))
p(HGNC:SULF2) -| tloc(a(HBP:"Tau isoform F (441 aa)"),fromLoc(GO:"extracellular region"),toLoc(GO:intracellular))

SET Evidence = "Overexpression of the constructs
was confirmed with immunocytochemistry and qPCR analysis (Fig. 4f and Supplementary Fig. 3d) and the
ability of the enzymes to reduce 6-O sulfation on the cell surface was confirmed by HPLC (Supplementary Fig. 3e,f)"
p(HGNC:SULF1) -| tloc(a(HBP:"Tau isoform F (441 aa)"),fromLoc(GO:"extracellular region"),toLoc(GO:intracellular))
p(HGNC:SULF1) -| a(HBP:"6-O-sulfated heparin")
p(HGNC:SULF2) -| tloc(a(HBP:"Tau isoform F (441 aa)"),fromLoc(GO:"extracellular region"),toLoc(GO:intracellular))
p(HGNC:SULF2) -| a(HBP:"6-O-sulfated heparin")
